Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents

por Lopez, Pio, Bravo, Lulu, Buntinx, Erik, Borja-Tabora, Charissa, Velasquez, Hector, Rodriquez, Edith Johana, Rodriguez, Camilo A., Carlos, Josefina, Montellano, May Emmeline B., Alberto, Edison R., Salvani-Bautista, Milagros, Huang, Yung, Hu, Branda, Li, Ping, Han, Htay Htay, Baccarini, Carmen, Smolenov, Igor
Publicado 2023